A MATHEMATICAL-MODEL FOR THE INHIBITION OF THE MULTIDRUG RESISTANCE-ASSOCIATED P-GLYCOPROTEIN PUMP

被引:3
|
作者
MICHELSON, S [1 ]
SLATE, D [1 ]
机构
[1] SYNTEX RES,INST BIOCHEM & CELL BIOL,PALO ALTO,CA 94303
关键词
D O I
10.1007/BF02460640
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
An extension of an earlier model of the p170 glycoprotein pump is presented. In an earlier work (Michelson and Slate, Bull. math. Biol. 54, 1023-1038, 1992), the pump was modeled using an energy-dependent model of facilitated diffusion. In this paper we add an inhibitor to the model. New equations are derived which represent either competitive or non-competitive inhibition in the pumping action of the glycoprotein. Numerical simulations were run which provide a response surface (initial loading concentration of inhibitor and its ability to compete with an ideal anti-cancer drug vs a summary measure of cytoplasmic exposure) for each scenario. The importance of the exposure profile. how it is related to ultimate tumor cell survival, and the binding requirements for developing multidrug resistance inhibitors are discussed.
引用
收藏
页码:207 / 223
页数:17
相关论文
共 50 条
  • [1] A MATHEMATICAL-MODEL OF THE P-GLYCOPROTEIN PUMP AS A MEDIATOR OF MULTIDRUG RESISTANCE
    MICHELSON, S
    SLATE, D
    BULLETIN OF MATHEMATICAL BIOLOGY, 1992, 54 (06) : 1023 - 1038
  • [2] Expression of Multidrug Resistance-Associated P-Glycoprotein in Feline Tumours
    Van der Heyden, S.
    Chiers, K.
    Vercauteren, G.
    Daminet, S.
    Wegge, B.
    Paepe, D.
    Ducatelle, R.
    JOURNAL OF COMPARATIVE PATHOLOGY, 2011, 144 (2-3) : 164 - 169
  • [3] EXPRESSION OF MULTIDRUG RESISTANCE-ASSOCIATED P-GLYCOPROTEIN IN FELINE TUMOURS
    Van der Heyden, S.
    Koen, C.
    Ducatelle, R.
    JOURNAL OF COMPARATIVE PATHOLOGY, 2009, 141 (04) : 311 - 311
  • [4] Expression of P-glycoprotein and Multidrug Resistance-associated Protein is Associated with Multidrug Resistance in Gastric Cancer
    Xu, H-W
    Xu, L.
    Hao, J-H
    Qin, C-Y
    Liu, H.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2010, 38 (01) : 34 - 42
  • [5] Atazanavir inhibits P-glycoprotein and multidrug resistance-associated protein efflux activity
    Lucia, MB
    Golotta, C
    Rutella, S
    Rastrelli, E
    Savarino, A
    Cauda, R
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 39 (05) : 635 - 637
  • [6] Decreased P-glycoprotein but unaltered multidrug resistance-associated protein in HIV patients
    Meaden, ER
    Brown, RA
    Hoggard, PG
    Maher, B
    Khoo, SH
    Back, DJ
    AIDS, 2000, 14 : S94 - S94
  • [7] How to probe clinical tumour samples for P-glycoprotein and multidrug resistance-associated protein
    Broxterman, HJ
    Lankelma, J
    Pinedo, HM
    EUROPEAN JOURNAL OF CANCER, 1996, 32A (06) : 1024 - 1033
  • [8] Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinoma
    Arts, HJG
    Katsaros, D
    de Vries, EGE
    Massobrio, M
    Genta, F
    Danese, S
    Arisio, R
    Scheper, RJ
    Kool, M
    Scheffer, GL
    Willemse, PHB
    van der Zee, AGJ
    Suurmeijer, AJH
    CLINICAL CANCER RESEARCH, 1999, 5 (10) : 2798 - 2805
  • [9] Schisandrin B: A dual inhibitor of P-glycoprotein and multidrug resistance-associated protein 1
    Sun, Meng
    Xu, Xiaoli
    Lu, Qinghua
    Pan, Qiangrong
    Hu, Xun
    CANCER LETTERS, 2007, 246 (1-2) : 300 - 307
  • [10] 99mTc-sestamibi is a substrate for P-glycoprotein and the multidrug resistance-associated protein
    NH Hendrikse
    EJF Franssen
    WTA van der Graaf
    C Meijer
    DA Piers
    W Vaalburg
    EGE de Vries
    British Journal of Cancer, 1998, 77 : 353 - 358